Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy

Medical Physics

Volumn 24, Issue 7, 1997, Pages 1163-1172

  Furhang, E E ^a   Chui, C S ^a   Kolbert, K S ^a   Larson, S M ^a   Sgouros, G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Monte Carlo; Patient specific dosimetry; Radioimmunotherapy

Indexed keywords

DOSIMETRY; ELECTRON TRANSPORT PROPERTIES; PATIENT TREATMENT; RADIOISOTOPES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ABSORBED DOSE DISTRIBUTION; DENSITY DISTRIBUTIONS; DOSE RESPONSE RELATIONSHIPS; MONTE CARLO DOSIMETRY; MONTE CARLO PROCEDURES; PATIENT SPECIFIC; RADIOACTIVITY DISTRIBUTION; RADIOIMMUNOTHERAPY;

MONTE CARLO METHODS;

IODINE 123; IODINE 124; IODINE 125; IODINE 131; RADIOISOTOPE;

ARTICLE; BONE MARROW; CANCER RADIOTHERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LEUKEMIA; LIVER; METASTASIS; PANCREAS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; SYSTEM ANALYSIS; THREE DIMENSIONAL IMAGING; THYROID CANCER;

EID: 0030796876     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.598018     Document Type: Article

References (24)

1. S. S. Snyder, M. R. Ford, G. G. Warner, and S. B. Watson, MIRD Pamphlet 11: "S," Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs (Society of Nuclear Medicine, New York, 1975).
2. G. Sgouros, G Barest, J. Thekkumthala, C. Chui, R. Mohan, R. E. Bigler, and P. B. Zanzonico, "Treatment planning for internal radionuclide therapy. Three-dimensional dosimetry for non-uniformly distributed radionuclides," J. Nucl. Med. 31, 1884-1891 (1990).
3. M. Tagesson, M Ljungberg, and S. E. Strand, "Transformation of activity distribution in quantitative SPECT to absorbed dose distribution in a radionuclide treatment planning system," J. Nucl. Med. 35, 123P (1994).
4. R Loevinger, T. F. Budinger, and E. E. Watson, MIRD Primer For Absorbed Dose Calculations (Society of Nuclear Medicine, New York, 1991).
5. P. C. Caron, J. G. Jurcic, A. M. Scott, R. D. Finn, C. R. Divgi, M. C. Graham, I. M. Jureidini, G. Sgouros, D. Tyson, L J. Old, S. M. Larson, and D A. Scheinberg, "A phase I B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogeniticity," Blood 83, 1760-1768 (1990).
6. H. B. Breitz, D. R. Fisher, P. L. Weiden, J. S. Durham, B. A. Ratliff, M. J. Bjorn, P. L. Beaumier, and P. G. Abrams, "Dosimetry of rhenium-186-labeled monoclonal antibodies: Methods, prediction from technetium-99m-labeled antibodies and results of phase I trials," J. Nucl. Med. 34, 908-917 (1993).
7. P. L. Weiden, H. B. Breitz, C. A. Seiler, M. J. Bjorn, B. A. Ratliff, R. Mallett, P. L. Beaumier, J. W. Appelbaum, A. R Fritzberg, and D. Salk, "Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10," J. Nucl. Med. 34, 2111-2119 (1993).
8. L. T. Dillman and F. C. Von derLage, MIRD Pamphlet 10: Radionuclide Decay Schemes and Nuclear Parameters for Use in Radiation-Dose Estimation (Society of Nuclear Medicine, New York, 1975).
9. W. S. Snyder, M. R. Ford, and G. G. Warner, MIRD Pamphlet 5 (revised) Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom (Society of Nuclear Medicine, New York, 1978).
10. D. A Weber, K. F. Eckerman, L. T. Dillman, and J. C. Ryman, MIRD: Radionuclide Data and Decay Schemes (Society of Nuclear Medicine, New York, 1989).
11. G. T. Y. Chen and C. A. Pelizzari, "Image correlation techniques in radiation therapy treatment planning," Comput. Med. Imaging Graphics 13, 235-240 (1989).
12. K. S. Kolbert, G. Sgouros, A. M. Scott, J. E Bronstein, R A. Malane, J. Zhang, H. Kalagian, S. McNamara, L. Schwartz, and S. M. Larson, "Implementation and evaluation of patient-specific three dimensional internal dosimetry," J. Nucl. Med. (to be published).
13. W. R. Nelson, H. Hirayama, and D. W. O. Rogers, "The EGS4 code system," SLAC Report No. 265 (SLAC, Stanford, CA, 1985).
14. H. E. Johns and J R. Cunningham, The Physics of Radiology, 4th ed. (Thomas, Springfield, IL. 1983).
15. E. E. Furhang, C. S. Chui, and G. Sgouros, "A Monte Carlo approach to patient-specific dosimetry," Med. Phys. 23, 1523-1529 (1996).
16. E. E. Furhang, "A Monte Carlo dosimetry method for patient-specific internal emitter therapy," Ph D. thesis, Columbia University, 1996.
17. A. B. Chilton, "A note on the fluence concept," Health Phys. 34, 715-516 (1977)
18. A B. Chilton, "Further comments on an alternate definition of fluence," Health Phys. 36, 637-638 (1978)
19. J. F. Williamson, "Monte Carlo evaluation of kerma at a point for photon transport problems," Med Phys. 14, 567-576 (1987).
20. Z F G. Jaworski, Proceedings of the First Workshop on Bone Morphology (University of Ottawa, Canada, 1976).
21. C R. Divgi, A M. Scott, L. Dantis, P. Capitelli, K. Siler, S Hilton, R. D. Finn, N. Kemeny, D. Kelsen, L. Kostakoglu, J. Schlom, and S. M. Larson, "Phase I radioimmunotherapy trial with iodine-131-CC49 in memstatic colon carcinoma," J. Nucl. Med. 36, 586-592 (1995).
22. H. Kalofonos, G. Rowlinson, and A. A. Epenetos, "Enhancement of monoclonal antibody uptake in human colon tumor exnografts following irradiation," Cancer Res 50, 159-163 (1990).
23. A. Maraveyas, M. Myers, N. Stafford, B. G. Rowlinson, and J. S. W. Stewart, "Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: Reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues," Cancer Res. 55, 1020-1027 (1995).
24. F. Buchegger, A. Rojas, A B. Delaloye, C. A. Vogel, R. O. Mirimanoff, P. Coucke, L. Q. Sun, S. Raimondi, J Denekamp, A. Pèlegrin, B. Delaloye, and J. P. Mach, "Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice," Cancer Res. 55, 83-89 (1995)